MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT |
AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
CQLS | CAPSULE CONTENT FORM | POWDER |
CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 120.000 |
FEAT | SPECIAL FEATURES | ACTIVE MEDICAMENT MEDICINAL STRENGTH:5.000 MILLIGRAMS OF CHLORDIAZEPOXIDE ACTIVE INGREDIENTS |